Linc AB

Linc AB

SSTO:LINC
68.40
SEK
+0.60
(+0.88%)
5.59EPS
12.71P/E
4.11BMarket Cap
Linc AB
STO:LINC
(Nasdaq Stockholm)

Recent

price

68.40

P/E

ratio

12.71

div

yld

- -

ROIC.AI

2018
2019
2020
2021
2022
2023
2024
2025
TTM
SEK
0.09
0.08
0.02
0.08
0.04
0.06
- -
0.09
0.03
Revenue per Share
5.14
9.71
13.56
-0.6
-12.49
10.7
22.48
-6.9
5.59
Basic EPS, GAAP
-0.32
0.02
-0.24
-7.02
-3.94
-1.39
0.51
-4.59
-4.76
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
17.34
27.04
40.6
62.73
50.24
60.94
83.42
76.51
77.92
Book Value per Share
17.34
27.04
40.6
62.73
50.24
60.94
83.42
76.51
77.92
Tangible Book Value per Share
61
61
61
50
58
58
58
58
58
Basic Weighted Avg Shares
6
5
1
4
2
4
- -
5
2
Sales/Revenue/Turnover
90.44
81.67
-121.89
-895.72
-37,872.71
17,774.33
- -
-8,468.62
18,417.41
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
316
596
833
-30
-723
619
1,302
-400
324
Net Income, GAAP
- -
1.06
14.13
- -
- -
7
- -
- -
2.58
Effective Tax Rate (%)
5,509.7
12,868.1
63,553.01
-725.69
-30,507.59
16,971.48
- -
-7,992.94
18,665.71
Profit Margin (%)
36
37
25
826
624
546
567
318
207
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
1,065
1,661
2,494
3,633
2,910
3,529
4,831
4,431
4,509
Total Equity
- -
43.71
40.09
- -
- -
18.74
- -
- -
7.46
Return on Invested Capital (%)
- -
43.74
40.1
- -
- -
19.24
- -
- -
7.77
Return on Capital (%)
- -
43.74
40.1
-0.98
-22.11
19.24
31.14
-8.63
7.76
Return on Common Equity (%)

Capital Structure

SEK

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
58
58
58
Market Capitalization
4,036
4,112
4,114

Working Capital

SEK

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
330
271
215
Cash, Cash Equivalents & STI
284
234
170
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
12
7
8
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

SEK

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
15.13%
-8.27%
Free Cash Flow
- -
217.41%
-995.16%
Net Income, GAAP
- -
399.79%
-130.7%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
5
- -
- -
- -
5
2026
1
- -
- -
- -
- -

Quarterly Earnings Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.06
17.97
-0.2
3.65
22.48
2025
-17.2
6.06
- -
-1.87
-6.9
2026
-3.05
4.46
- -
- -
- -

Quarterly Dividends Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Linc AB operates as an investment company, specializing in both private equity and venture capital, with a dedicated focus on the Nordic life science industry. The firm directs its capital toward product-oriented businesses, primarily within the pharmaceutical and medical technology sectors. Linc strategically invests across various development stages, typically engaging in pharmaceutical endeavors during earlier phases, while entering medical technology ventures at more mature points. The company, which successfully completed its initial public offering on Nasdaq Stockholm in May 2021, prefers to secure long-term share ownership in these companies, encompassing both publicly traded and privately held entities. Investments typically range from SEK 25 million to SEK 250 million, often starting with a smaller initial commitment that is then augmented by subsequent, more substantial follow-on investments. Linc acts as an active, long-term owner, providing not just financial backing but also valuable expertise, extensive industry networks, and strategic support to its portfolio companies. The company is headquartered in Stockholm, Sweden.